Nomura Research Institute, Ltd.
NRILY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $765 | $737 | $692 | $612 |
| % Growth | 3.8% | 6.4% | 13.2% | – |
| Cost of Goods Sold | $490 | $476 | $452 | $396 |
| Gross Profit | $275 | $261 | $240 | $216 |
| % Margin | 36% | 35.4% | 34.6% | 35.3% |
| R&D Expenses | $0 | $0 | $5 | $5 |
| G&A Expenses | $144 | $142 | $132 | $114 |
| SG&A Expenses | $144 | $142 | $126 | $108 |
| Sales & Mktg Exp. | $0 | $0 | -$6 | -$6 |
| Other Operating Expenses | -$4 | -$2 | $0 | $0 |
| Operating Expenses | $140 | $141 | $131 | $113 |
| Operating Income | $135 | $120 | $112 | $103 |
| % Margin | 17.6% | 16.3% | 16.2% | 16.8% |
| Other Income/Exp. Net | -$1 | -$3 | -$3 | $2 |
| Pre-Tax Income | $134 | $117 | $108 | $104 |
| Tax Expense | $40 | $37 | $32 | $33 |
| Net Income | $94 | $80 | $76 | $71 |
| % Margin | 12.3% | 10.8% | 11% | 11.7% |
| EPS | 163.56 | 136.9 | 128.92 | 120.57 |
| % Growth | 19.5% | 6.2% | 6.9% | – |
| EPS Diluted | 163.56 | 136.84 | 128.88 | 120.34 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $3 | $2 | $2 |
| Interest Expense | $6 | $7 | $6 | $4 |
| Depreciation & Amortization | $49 | $48 | $45 | $42 |
| EBITDA | $189 | $167 | $155 | $145 |
| % Margin | 24.7% | 22.7% | 22.3% | 23.6% |